- Coordinator
- Oils4cure SL, Spain
- Runs
- 1 December 2023 to 31 August 2026
- Status
- Running
- EU funding
- €1.6m
- Total cost
- €2.2m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190119321
What the project is doing
In the project's own words, from its summary on CORDIS.
OILS4CURE is a Spanish biotech company dedicated to the research, development, production and commercialisation of medicinal products based on full spectrum medicinal cannabis extracts. It is developing a drug to manage refractory epilepsy associated with tuberous sclerosis complex (YCJ-01) and another for Leukodystrophies (YCJ-02), both paediatric rare diseases. This project only deals with the development of our first and most advanced therapy directed at tuberous sclerosis complex (TSC).
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Oils4cure SL | Madrid | Spain | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI